GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kaken Pharmaceutical Co Ltd (TSE:4521) » Definitions » Cyclically Adjusted Book per Share

Kaken Pharmaceutical Co (TSE:4521) Cyclically Adjusted Book per Share : 円3,079.64 (As of Dec. 2023)


View and export this data going back to 1961. Start your Free Trial

What is Kaken Pharmaceutical Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Kaken Pharmaceutical Co's adjusted book value per share for the three months ended in Dec. 2023 was 円3,700.432. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is 円3,079.64 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Kaken Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 9.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 10.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Kaken Pharmaceutical Co was 10.70% per year. The lowest was 9.80% per year. And the median was 10.00% per year.

As of today (2024-05-22), Kaken Pharmaceutical Co's current stock price is 円3436.00. Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was 円3,079.64. Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 1.12.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kaken Pharmaceutical Co was 3.70. The lowest was 1.06. And the median was 2.04.


Kaken Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kaken Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Kaken Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,927.49 2,113.32 2,315.78 2,568.23 2,864.47

Kaken Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,808.21 2,864.47 2,935.67 3,013.95 3,079.64

Competitive Comparison of Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.



Kaken Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Kaken Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3700.432/106.8000*106.8000
=3,700.432

Current CPI (Dec. 2023) = 106.8000.

Kaken Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 1,611.715 95.700 1,798.654
201406 1,589.230 98.000 1,731.936
201409 1,642.864 98.500 1,781.298
201412 1,708.521 97.900 1,863.841
201503 1,861.066 97.900 2,030.254
201506 1,952.070 98.400 2,118.710
201509 2,065.909 98.500 2,239.991
201512 2,224.236 98.100 2,421.492
201603 2,170.565 97.900 2,367.889
201606 2,174.864 98.100 2,367.742
201609 2,287.989 98.000 2,493.441
201612 2,387.395 98.400 2,591.197
201703 2,511.640 98.100 2,734.385
201706 2,564.274 98.500 2,780.350
201709 2,688.583 98.800 2,906.282
201712 2,767.934 99.400 2,973.997
201803 2,824.280 99.200 3,040.656
201806 2,820.949 99.200 3,037.070
201809 2,950.215 99.900 3,153.984
201812 2,977.235 99.700 3,189.255
201903 3,049.751 99.700 3,266.935
201906 3,067.364 99.800 3,282.510
201909 3,165.166 100.100 3,377.020
201912 3,251.768 100.500 3,455.610
202003 3,301.042 100.300 3,514.968
202006 3,340.349 99.900 3,571.064
202009 3,417.024 99.900 3,653.035
202012 3,444.324 99.300 3,704.469
202103 3,555.890 99.900 3,801.492
202106 3,561.796 99.500 3,823.114
202109 3,657.705 100.100 3,902.526
202112 3,678.438 100.100 3,924.647
202203 3,642.275 101.100 3,847.626
202206 3,643.005 101.800 3,821.935
202209 3,730.790 103.100 3,864.679
202212 3,739.332 104.100 3,836.318
202303 3,636.148 104.400 3,719.738
202306 3,662.727 105.200 3,718.434
202309 3,755.461 106.200 3,776.678
202312 3,700.432 106.800 3,700.432

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Kaken Pharmaceutical Co  (TSE:4521) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kaken Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=3436.00/3079.64
=1.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Kaken Pharmaceutical Co was 3.70. The lowest was 1.06. And the median was 2.04.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Kaken Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Kaken Pharmaceutical Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Kaken Pharmaceutical Co (TSE:4521) Business Description

Traded in Other Exchanges
Address
28-8, Honkomagome 2-chome, Bunkyo-ku, Tokyo, JPN, 1138650
Kaken Pharmaceutical Co is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Kaken Pharmaceutical Co (TSE:4521) Headlines

No Headlines